The actress first started as an assistant director to Bhansali on Priyanka Chopra’s Mary Kom that came out in 2014. And as per reports, was paid Rs 7,500 as her first salary
read more
The maverick filmmaker of the entertainment industry, Sanjay Leela Bhansali recently amazed the viewers with his latest project Heeramandi: The Diamond Bazaar, which premiered on 1st on Netflix.
The web series was a visual spectacle amalgamating top-notch direction and impeccable performances. However, the weakest link in the web series turned out to be Sharmin Segal, who portrayed the character of Alamzeb.
Sharmin garnered severe criticism for her performance in Heeramandi as netizens ’expressionless’ and her acting skills, ‘abysmal.’ In fact, she disabled the comment section of her Instagram profile due to the growing backlash against her. Having said that, her journey may not have been as easy as it seems.
The actress first started as an assistant director to Bhansali on Priyanka Chopra’s Mary Kom that came out in 2014. And as per reports, was paid Rs 7,500 as her first salary.
She then made her acting debut with Malaal in 2019, produced by SLB. And five years later, the middling show Heeramandi happened.
Ever since the release of Netflix’s Heeramandi, Sharmin Segal, who played the role of Alamzeb, has been garnering severe criticism for her performance in Sanjay Leela Bhansali’s web series. While she has been the talk of the town, very few people know about her husband Aman Mehta, who has an insane net worth of Rs 53,800 crore.
Aman Mehta, who tied the knot with Sharmin Segal in November 2023, works as an Executive Director for Torrent Pharmaceuticals, a division of Torrent Group. The firm’s portfolio include Torrent Pharma, Torrent Power, Torrent Cables, Torrent Gas, and Torrent Diagnostics.
Headquartered in Ahmedabad, it was founded by U. N. Mehta in 1959. The in-charge of Torrent Group are Aman’s father, Samir Mehta, and his brother, Sudhir Mehta.
As per Bloomberg’s Index, the net worth of Aman’s father Samir Mehta is humongous $6.44 billion (about Rs 53,800 crore) as of 2024. Torrent Pharma made $4.6 billion in revenue, or about Rs 38,412 crore as per a Forbes report.
